News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Treating Epilepsy: Key Takeaways From AES 2020

EP. 1: Phase 4 ELEVATE Study

ByTrevor J. Resnick, MD,Amit Verma, MD

January 13th 2021

EP. 2: Clinical Benefit of Fenfluramine in Dravet Syndrome

ByTrevor J. Resnick, MD,Amit Verma, MD

January 14th 2021

EP. 3: Safety and Efficacy of CBD in Patients With TSC

ByTrevor J. Resnick, MD,Amit Verma, MD

January 17th 2021

EP. 4: ELEKTRA Study in Dravet and Lennox-Gastaut Syndromes

ByTrevor J. Resnick, MD,Amit Verma, MD

January 19th 2021

EP. 5: Focal Seizures: Post-hoc Analysis of Cenobamate

ByTrevor J. Resnick, MD,Amit Verma, MD

January 20th 2021

EP. 6: FAME Study: Partial-Onset Seizures

ByTrevor J. Resnick, MD,Amit Verma, MD

February 4th 2021

EP. 7: BELIEVE Trial: Developmental and Epileptic Encephalopathies

ByTrevor J. Resnick, MD,Amit Verma, MD

February 8th 2021

EP. 8: Interim Analysis of Diazepam Nasal Spray in Epilepsy

ByTrevor J. Resnick, MD,Amit Verma, MD

February 9th 2021

EP. 9: Using Midazolam Nasal Spray for Seizure Clusters

ByTrevor J. Resnick, MD,Amit Verma, MD

February 15th 2021

EP. 10: QoL of Cenobamate in Treatment-Resistant Epilepsy

ByTrevor J. Resnick, MD,Amit Verma, MD

February 17th 2021

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation

FDA Fast Tracks Etalanetug, Encouraging Interim TEMPO-4 Data, Initial Data on Cell Therapy UX-DA001

NeurologyLive® Friday 5 — October 24, 2025

Smartphone-Based App for Muscular Relaxation Significantly Reduces Migraine-Related Disability in Emergency Room Settings

Incidence and Prevalence of Frontotemporal Dementia Similar to Dementia with Lewy Bodies, Meta-Analysis Shows

© 2025 MJH Life Sciences^®

All rights reserved.